Home Authors Posts by Anna Betchel

Anna Betchel

9 POSTS 0 COMMENTS

Recent Articles

New Chapter 11 Filings, Disclosures: April 12 – April 16, 2021

At least two major companies have either filed for Chapter 11 bankruptcy protection or defaulted on loans during the week of April...

ViacomCBS Networks International Agrees to Acquire Chilevisión

On Monday April 5, ViacomCBS Inc. (NASDAQ: VIAC, VIACA) announced that it had agreed to acquire Chilevisión from WarnerMedia. WarnerMedia is a...

Carnival Reports $2 Billion Quarterly Loss

Carnival reports $2 billion quarterly loss. This is due to COVID-19 pandemic restrictions on the cruising industry, which has decimated Carnival and...

New High Yield Bond Ratings: April 5 – 9, 2021

At least 35 companies received a revision on high yield bond ratings during the week of April 5-9, 2021. These revisions caused...
ECB President Christine Lagarde

ECB President Lagarde Expects Strong Rebound for EU Economy in Second Half

Despite COVID-19 struggles, European Central Bank (ECB) President Christine Lagarde told CNBC on April 9 that the European Union (EU) will hit...

Most Popular

U.S. Treasury Secretary Janet Yellen Corporate Tax

Treasury Secretary Yellen Calls for Global Minimum Corporate Tax

U.S. Treasury Secretary Janet Yellen said on April 5 that she is working with G20 countries to agree on a global minimum...

Prelude Therapeutics Files for Its IPO

Prelude Therapeutics Incorporated files for its IPO. According to the S-1 filing, the IPO will see the company trade shares on the...

Shipping Giants Ride Coattails of Online Retail Surge

The COVID-19 pandemic has undoubtedly had a profound impact on the global economy, but those impacts have varied across sectors. While many...

Endologix Files for Chapter 11 Bankruptcy

Medical device company Endologix, Inc. initiated Chapter 11 bankruptcy on July 6. The California-based developer of treatments for aortic disorders also filed...

James Woody Explores New Horizons in Enosi Life Sciences

Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense leadership skills, Dr. James holds over 25 years of experience in the pharmaceutical, venture capital, and biotech sectors. He also possesses medical expertise in antibody therapeutics and oncology.